$17.030
0.000 (0.00%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TBPH por análisis de gráficos similares
Alphio's TBPH stock price prediction model matches the current Theravance Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.47 (+2.59%). The 1-week path is $16.49 (-3.18%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Theravance Biopharma Inc?
Theravance Biopharma is currently a hold. The stock is trading at $17.02, which is very close to the acquisition price of $17.00 per share set by Zymeworks. The recent downgrade from Jones Trading reflects caution regarding the company's future performance, particularly after the acquisition announcement. Additionally, the RSI is at 41.36, indicating that the stock is neither overbought nor oversold, suggesting a neutral position. The main risk is the uncertainty surrounding the acquisition and the company's future earnings potential, especially after the CYPRESS trial did not meet its primary endpoint, which could impact future revenue streams.
TBPH cerró en $17.03 el Wednesday, tras subir 0.00%
Theravance Biopharma Inc (TBPH) last closed at $17.03, gaining +0.00%. These facts feed the 1-day and 1-week TBPH price prediction above.
Consenso de analistas
Theravance Biopharma Inc (TBPH): 4 comprar, 0 mantener, 3 vender. Perspectiva: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Theravance Biopharma Inc (TBPH) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TBPH, ordenadas por similitud.
Análisis de estacionalidad de TBPH
Historically the probability of a positive October return for TBPH is 50.00%. February offers the highest probability of a positive month at 55.17%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TBPH
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $11.44 | $12.54 | $12.64 | -26.34% |
| Nov 2026 | $9.84 | $12.93 | $15.45 | -24.06% |
| Dec 2026 | $9.91 | $10.34 | $12.29 | -39.30% |
En 2026, se proyecta que Theravance Biopharma Inc (TBPH) oscile entre $9.84 y $15.45.
Previsión mensual de Theravance Biopharma Inc para 2026
En Oct de 2026, se proyecta que Theravance Biopharma Inc promedie $12.54, con un mínimo de $11.44 y un máximo de $12.64.
En Nov de 2026, se proyecta que Theravance Biopharma Inc promedie $12.93, con un mínimo de $9.84 y un máximo de $15.45.
En Dec de 2026, se proyecta que Theravance Biopharma Inc promedie $10.34, con un mínimo de $9.91 y un máximo de $12.29.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.